Infanrix (DTaP) Interactions
There are 299 drugs known to interact with Infanrix (DTaP) (diphtheria and tetanus toxoids/pertussis, acellular), along with 4 disease interactions. Of the total drug interactions, 1 is major, 295 are moderate, and 3 are minor.
- View all 299 medications that may interact with Infanrix (DTaP)
- View Infanrix (DTaP) disease interactions (4)
Most frequently checked interactions
View interaction reports for Infanrix (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular) and the medicines listed below.
- acetaminophen / oxycodone
- Acetylsalicylic Acid (aspirin)
- ActHIB (haemophilus b conjugate (prp-t) vaccine)
- amlodipine
- Apidra SoloStar (insulin glulisine)
- Arexvy (rsv vaccine pref3, recombinant)
- atorvastatin
- Bactroban (mupirocin topical)
- Benadryl (diphenhydramine)
- biotin
- cephalexin
- cetirizine
- citric acid/magnesium oxide/sodium picosulfate
- Claritin 24 Hour Allergy (loratadine)
- Crestor (rosuvastatin)
- cyclopentolate ophthalmic
- dapagliflozin
- dimenhydrinate
- diphenhydramine
- docusate
- Engerix-B Pediatric (hepatitis b pediatric vaccine)
- ezetimibe
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Fluzone High-Dose Quadrivalent (influenza virus vaccine, inactivated)
- Gardasil 9 (human papillomavirus vaccine)
- Glumetza (metformin)
- glyburide
- H-BIG (hepatitis b immune globulin)
- Havrix Pediatric (hepatitis a pediatric vaccine)
- Rotarix (rotavirus vaccine)
Infanrix (DTaP) disease interactions
There are 4 disease interactions with Infanrix (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular) which include:
Report options
QR code containing a link to this page
More about Infanrix (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular)
- Infanrix (DTaP) consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: vaccine combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.